Phenolic compounds like resveratrol, chlorogenic acid, caffeic acid, dihydromyricetin, quercetin, catechins, and curcumin may activate AMPK, reducing SREBP-1c expression, offering the potential for MASLD prevention and treatment [143]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.